Novabay Pharmaceuticals, Inc. approved to elect Mijia (Bob) Wu Class I directors nominated by the Company's Board of Directors to hold office for a term of three (3) years or until their respective successors are elected and qualified.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.835 USD | -1.56% | -50.34% | -60.29% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.29% | 3.32M | |
+53.41% | 55.7B | |
+41.08% | 39.91B | |
-5.70% | 39.57B | |
-5.56% | 28.16B | |
+16.52% | 26.3B | |
-20.22% | 18.94B | |
+32.87% | 12.17B | |
+26.80% | 12.12B | |
+2.19% | 12.12B |
- Stock Market
- Equities
- NBY Stock
- News NovaBay Pharmaceuticals, Inc.
- Novabay Pharmaceuticals, Inc. Approves to Elect Mijia Wu as Director